ciprofloxacin has been researched along with Pulmonary Eosinophilia in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Pulmonary Eosinophilia: A condition characterized by infiltration of the lung with EOSINOPHILS due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akcaer, M | 1 |
| Karakas, A | 1 |
| Tok, D | 1 |
| Coskun, O | 1 |
| Sari, S | 1 |
1 other study available for ciprofloxacin and Pulmonary Eosinophilia
| Article | Year |
|---|---|
Eosinophilic pneumonia: Daptomycin-induced lung complication.
Topics: Abscess; Amputation Stumps; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Combined Modality The | 2016 |